Recruiting Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction NCT07224529 Conditions Dry Eye Syndromes, Eye Diseases, Eyelid Diseases, +3 more Locations University of Alabama at Birmingham, School of Optometry, Clinical Eye Research Facility — Birmingham, Alabama, United States View Trial Details
Completed Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blepharitis Using Artificial Intelligent Program (Ai-Demodex) NCT07169461 Conditions Demodex Blepharitis, Eye Diseases, Eyelid Diseases, +2 more Locations Chulalongkorn University — Pathum Wan, Bangkok, Thailand View Trial Details
Completed An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD) NCT03972501 Conditions Contact Lens Discomfort (CLD), Eye Diseases, Eyelid Diseases, +2 more Locations School of Optometry and Vision Science, University of New South Wales — Sydney, New South Wales, Australia View Trial Details
Completed A Post-Market Evaluation of LipiFlow Treatment in Cataract Surgery Practice NCT03708367 Conditions Cataract, Cataracts, Eye Diseases, +4 more Locations Empire Eye & Laser Center, Inc. — Bakersfield, California, United States Eye Doctors of Washington — Chevy Chase, Maryland, United States Matossian Eye Associates — Pennington, New Jersey, United States JW Eye Associates, P.A. — Dallas, Texas, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed The Effect of an Eyelid Warming Device for the Management of Meibomian Gland Dysfunction NCT02284997 Conditions Eye Diseases, Eyelid Diseases, Meibomian Gland Dysfunction, +1 more Locations Centre for Contact Lens Research, University of Waterloo — Waterloo, Ontario, Canada View Trial Details
Completed Treatment of Meibomian Gland Dysfunction NCT01683318 Conditions Eye Diseases, Eyelid Diseases, Meibomian Gland Dysfunction, +1 more Locations Singapore National Eye Centre — Singapore View Trial Details
